Editorial Article: Advances in CAR T Therapy: Reprogramming Patient Cells to Treat Cancer – SelectScience
|
Editorial Article: Advances in CAR T Therapy: Reprogramming Patient Cells to Treat Cancer
SelectScience Chimeric antigen receptor modified T cell (CAR T) therapy is an emerging immunotherapy that involves the genetic engineering and 'supercharging' of patients' own immune cells to treat their cancer. In this SelectScience® interview, Dr. Richard Jones … |
